U.S. markets closed

Jounce Therapeutics, Inc. (JNCE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.27+0.58 (+8.67%)
At close: 1:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 11/27/2020
Current
9/30/20206/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
266.61M279.78M235.05M161.73M294.53M110.64M
Enterprise Value 3
180.00M170.95M107.18M12.68M139.19M-20.28M
Trailing P/E
11.8012.555.482.863.85N/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
2.242.381.741.101.761.73
Price/Book (mrq)
2.542.201.540.931.541.23
Enterprise Value/Revenue 3
1.29N/AN/AN/AN/A-0.17
Enterprise Value/EBITDA 6
-1.79-7.04-3.91-0.48-6.16-0.21

Trading Information

Stock Price History

Beta (5Y Monthly) 1.67
52-Week Change 311.50%
S&P500 52-Week Change 316.84%
52 Week High 311.72
52 Week Low 32.85
50-Day Moving Average 38.19
200-Day Moving Average 36.74

Share Statistics

Avg Vol (3 month) 31.3M
Avg Vol (10 day) 3276.63k
Shares Outstanding 539.85M
Float 18.08M
% Held by Insiders 123.14%
% Held by Institutions 163.45%
Shares Short (Nov 12, 2020) 41.44M
Short Ratio (Nov 12, 2020) 43.86
Short % of Float (Nov 12, 2020) 46.27%
Short % of Shares Outstanding (Nov 12, 2020) 43.60%
Shares Short (prior month Oct 14, 2020) 4954.18k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-36.32%
Return on Equity (ttm)-68.79%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)122M
EBITDA -100.52M
Net Income Avi to Common (ttm)-101.98M
Diluted EPS (ttm)-3.01
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)104.25M
Total Cash Per Share (mrq)2.62
Total Debt (mrq)17.64M
Total Debt/Equity (mrq)16.79
Current Ratio (mrq)6.60
Book Value Per Share (mrq)3.07

Cash Flow Statement

Operating Cash Flow (ttm)-85.73M
Levered Free Cash Flow (ttm)-46.91M